Shenzhen Neptunus Interlong Bio-Technique Company Limited (NEP Interlong) filed its Monthly Return for April 2026, confirming that both authorised and issued share capital remained unchanged during the period.
Total Share Capital • Authorised / registered capital: 426.00 million ordinary H shares at a par value of RMB 0.10, equating to RMB 42.60 million. • Issued shares: 426.00 million H shares and 1.252 billion domestic shares, bringing total issued shares to 1.678 billion.
Share Movements • No new shares were issued, cancelled, or repurchased. • Treasury shares: none on record. • No share options, warrants, convertible securities, or other equity-linked instruments were outstanding or exercised.
Public Float • The company confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float requirement of 25% for its H-share class as at 30 April 2026.
Registrar Confirmation Tricor Investor Services Limited, acting as H-share registrar, submitted the return on 4 May 2026.
The filing indicates capital stability for NEP Interlong with full adherence to listing regulations and no dilution or enhancement events during the month.
Comments